摘要
多功能的治疗诊断试剂已经成为治疗肿瘤的冒险之举,因为其可以整合肿瘤的诊断和治疗。多功能的theranostic剂可以通过抗癌药物和各种癌症靶向配体的造影剂的化学偶联来探索获得。另一种方法是基于纳米探针,通过EPR效应或靶配体共轭,肿瘤靶向纳米结构可以实现同步的癌症特异性检测和治疗。有趣的是,最近有报道称发现了一个新兴的多功能小分子癌症靶向诊断治疗试剂。考虑到治疗诊断试剂的快速发展和对其发迫切需求,本文讨论了目前采用的和新出现的制备方法,并强调在每种方法的优点和挑战,以此来提供一个对发展更多的适合临床需求的癌症诊断剂的深刻见解。
关键词: 癌症治疗诊断,多功能剂,近红外成像,菁染料,纳米聚合物试剂。
Current Medicinal Chemistry
Title:Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy
Volume: 23 Issue: 5
Author(s): Shenglin Luo, Xiaochao Yang, Chunmeng Shi
Affiliation:
关键词: 癌症治疗诊断,多功能剂,近红外成像,菁染料,纳米聚合物试剂。
摘要: The development of multifunctional theranostic agents has become an intriguing venture for personalized oncology, because they can integrate tumor diagnosis and therapy. One approach explored to obtain such multifunctional theranostic agents is through the chemical conjugation of anticancer drugs and contrast agents with various cancer-targeted ligands. The other approach is based on the nanoplatform, in which cancer-targeted nanostructures achieve simultaneous cancer specific detection and therapeutics either by EPR effect or by conjugation of target ligands. Interestingly, a newly emerging strategy from multifunctional small molecules to develop cancertargeted theranostic agents has been reported recently. In consideration of the urgent need and rapid development of theranostic agents in cancer therapy, herein we review the currently adopted and newly emerging approaches for their preparation, and highlight the promises and challenges in each approach, hoping to offer useful insights in developing more specific and efficient cancer theranostic agents suitable for clinical use.
Export Options
About this article
Cite this article as:
Shenglin Luo, Xiaochao Yang, Chunmeng Shi , Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy, Current Medicinal Chemistry 2016; 23 (5) . https://dx.doi.org/10.2174/0929867323666151223095718
DOI https://dx.doi.org/10.2174/0929867323666151223095718 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neglected Aspects of Drug Discovery - Microbiological Aspects
Current Clinical Pharmacology Influence of Prebiotics on the Human Immune System (GALT)
Recent Patents on Inflammation & Allergy Drug Discovery Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study
Current Nutrition & Food Science Towards a Personalised Approach to Managing Influenza Infections in Infants and Children – Food for Thought and a Note on Oseltamivir
Infectious Disorders - Drug Targets Cancer Vaccines: Emphasis on Pediatric Cancers
Current Pharmaceutical Design PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) Nanoparticles as Carriers for SN-38: Design, Optimization and Nano-Bio Interface Interactions
Current Drug Delivery Modulation of Mitochondrial and Epigenetic Targets by Polyphenols-rich Extract from Araucaria angustifolia in Larynx Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
Current Medicinal Chemistry The Role of FDA in the Regulation of Anti-Cancer Drugs
Current Cancer Therapy Reviews Patent Selections
Recent Patents on Mechanical Engineering Synthesis and Investigation of Therapeutic Potential of Isoform-Specific HDAC8 Inhibitors for the Treatment of Cutaneous T Cell Lymphoma
Anti-Cancer Agents in Medicinal Chemistry The Role of Autophagic Cell Death and Apoptosis in Irinotecan-treated p53 Null Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies
Current Pharmaceutical Biotechnology Gene Vectors for Cytokine Expression In Vivo
Current Pharmaceutical Design Plasmid DNA Manufacturing Technology
Recent Patents on Biotechnology Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent
Anti-Cancer Agents in Medicinal Chemistry Novel Diagnostic Biomarkers of Prostate Cancer: An Update
Current Medicinal Chemistry Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Current Medicinal Chemistry BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer
Current Drug Targets Understanding the Interaction Between Human Serum Albumin and Anti-Bacterial/ Anti-Cancer Compounds
Current Pharmaceutical Design